Bromide

Bromide

SCHEMBL813973

CC(C)c1cc(C(C)C)c(NCCCN(C)CCNc2c(C(C)C)cc(C(C)C)cc2C(C)C)c(C(C)C)c1.[Br-].[Br-].[Co+2]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 2/20 0.32
BCHE P06276 2/20 0.32
HPGD P15428 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
FABP3 P05413 1/20 0.30
FABP4 P15090 1/20 0.30
NPC1 O15118 1/20 0.30
POLB P06746 1/20 0.30
SLC2A1 P11166 1/20 0.30
APOBEC3A P31941 1/20 0.30
RAD52 P43351 1/20 0.30
RAB9A P51151 1/20 0.30
KMT2A Q03164 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL814756 0.97 BCHE (0.32) BCHEACHEHPGDGABRA1GABRB2
Bromide SCHEMBL813770 0.97 BCHE (0.33) BCHEACHEHPGDGABRA1GABRB2
Hydrochloric Acid SCHEMBL813331 0.94 BCHE (0.33) BCHEACHEHPGDGABRA1GABRB2
Bromide SCHEMBL814321 0.94 GABRA1 (0.34) GABRA1GABRB2FABP3FABP4
Hydrochloric Acid SCHEMBL813812 0.91 GABRA1 (0.34) GABRA1GABRB2FABP3FABP4
SCHEMBL815100 0.89 GABRA1 (0.35) GABRA1GABRB2FABP3FABP4
Hydrochloric Acid SCHEMBL813257 0.89 GABRA1 (0.35) GABRA1GABRB2FABP3FABP4
SCHEMBL814042 0.89 GABRA1 (0.35) GABRA1GABRB2FABP3FABP4
SCHEMBL813581 0.89 GABRA1 (0.35) GABRA1GABRB2FABP3FABP4
SCHEMBL813661 0.89 GABRA1 (0.35) GABRA1GABRB2FABP3FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058372-B2 Catalyst composition II EXXONMOBIL CHEMICAL PATENTS INC. (US) 2011-11-15 US disclosed
US-20080319147-A1 Catalyst Composition II EXXONMOBIL CHEMICAL PATENTS INC. 2008-12-25 US disclosed
US-7371803-B2 Catalyst composition II EXXONMOBIL CHEMICAL PATENTS INC. (US) 2008-05-13 US disclosed
US-20070066776-A1 Catalyst composition II SOLAN GREGORY A 2007-03-22 US disclosed
US-7189791-B2 Catalyst composition II EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-03-13 US disclosed
US-20040266961-A1 Catalyst composition II EXXONMOBIL CHEMICAL PATENTS INC. 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266961-A1 Catalyst composition II MLX, CBX2, BMX ACHE 3557/4885BCHE 3414/4885HPGD 3572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.